Jennifer Dines, MD is a highly accomplished and experienced medical professional who has made significant contributions in the field of precision medicine, specifically in autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. With a background in neurobiology and neurosciences, Jennifer has held key positions in various organizations such as Scipher Medicine and Adaptive Biotechnologies Corp, focusing on clinical development, regulatory affairs, and medical strategy. Their expertise in translational medicine, medical genetics, and neuroimaging has made their an invaluable asset in driving successful product launches, engaging with regulatory bodies, and leading cross-functional teams to deliver innovative solutions in healthcare.
July 1, 2023 - present
May, 2022